$ENZ ENZO BIOCHEM INC Insider Trading
Get free email notifications about insider trading in ENZO BIOCHEM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENZO BIOCHEM INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ENZO BIOCHEM INC for free.
IRS Number: 132866202
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Trading Symbol: ENZ
Company Address: ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE 11735
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. It operates through the following segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactures, and markets products to research and pharmaceutical customers. The Clinical Services segment provides diagnostic services to the health care community. The Therapeutics segment conducts research and development activities for therapeutic drug candidates. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
Market Capitalization: $301.34M
Prev close: $6.78
Average Daily Volume: 169,210
Days Low: $6.40
Year Low: $4.00
Year High: $7.51
ENZO BIOCHEM INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 4.54 | 100,000 | 453,900 | 5,175,913 | 5.3 M to 5.2 M (-1.90 %) |
| Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 4.70 | 200,000 | 940,000 | 5,275,913 | 5.5 M to 5.3 M (-3.65 %) |
| Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 5.00 | 44,768 | 223,840 | 5,475,913 | 5.5 M to 5.5 M (-0.81 %) |
| Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 4.75 | 100,000 | 475,000 | 5,520,681 | 5.6 M to 5.5 M (-1.78 %) |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | TAGLIAFERRI MARY | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | TAGLIAFERRI MARY | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | PRESIDENT AND TREAS ... | Grant | A | 0.00 | 142,586 | 0 | 1,657,499 | 1.5 M to 1.7 M (+9.41 %) |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | PRESIDENT AND TREAS ... | Grant | A | 0.00 | 142,586 | 0 | 1,657,499 | 1.5 M to 1.7 M (+9.41 %) |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Fischer Rebecca J. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 160,434 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 190,114 | 0 | 2,262,208 | 2.1 M to 2.3 M (+9.17 %) |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 335,780 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Fischer Rebecca J. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 160,434 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Bench David | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.63 | 55,400 | 145,702 | 110,800 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Walters Ian B. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
| Jan 13 2021 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 190,114 | 0 | 2,262,208 | 2.1 M to 2.3 M (+9.17 %) |